10x Genomics (TXG) Other Non Operating Income (2018 - 2026)

10x Genomics has disclosed Other Non Operating Income across 9 years of filings, most recently posting -$815000.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$815000.0, down 138.16% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 273.22% YoY), and the FY2025 annual result was $1.0 million, up 149.83% from the prior year.
• Other Non Operating Income came in at -$815000.0 for Q1 2026 at 10x Genomics, up from -$2.5 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $4.0 million in Q4 2022 to a low of -$3.0 million in Q4 2024.
• The 5-year median for Other Non Operating Income is -$1.0 million (2024), against an average of -$137411.8.
• Peak annual rise in Other Non Operating Income reached 79800.0% in 2022, while the deepest fall reached 453.74% in 2022.
• 10x Genomics' Other Non Operating Income stood at $4.0 million in 2022, then declined by 0.33% to $4.0 million in 2023, then tumbled by 176.57% to -$3.0 million in 2024, then increased by 16.56% to -$2.5 million in 2025, then jumped by 67.96% to -$815000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$815000.0 (Q1 2026), -$2.5 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.